ATX-S10(Na)-photodynamic therapy is less carcinogenic for mouse skin compared with ultraviolet B irradiation

British Journal of Dermatology

Volumn 153, Issue 6, 2005, Pages 1182-1186

  Takahashi, Hidetoshi ^a   Nakajima, S ^b   Sakata, I ^c   Ishida Yamamoto, A ^a   Iizuka, H ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c Photochemical Co Ltd   (Japan)

Author keywords

ATX S10(Na); Carcinogenesis; Photodynamic therapy; Photoproducts

Indexed keywords

13,17 BIS(1 CARBOXYPROPIONYL)CARBAMOYLETHYL 8 ETHENYL 2 HYDROXY 3 HYDROXYIMINOETHYLIDENE 2,7,12,18 TETRAMETHYLPORPHYRIN SODIUM; 8 HYDROXYDEOXYGUANOSINE; PHOTOSENSITIZING AGENT; PYRIMIDINE DIMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA STRAND BREAKAGE; EXPERIMENTAL NEOPLASM; FEMALE; KERATINOCYTE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN TUMOR; SPECIES COMPARISON; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DEOXYGUANOSINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; KERATINOCYTES; MICE; MICE, INBRED HRS; NEOPLASMS, RADIATION-INDUCED; PHOTOCHEMOTHERAPY; PORPHYRINS; PYRIMIDINE DIMERS; SKIN; SKIN NEOPLASMS; ULTRAVIOLET THERAPY;

EID: 28844467204     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06937.x     Document Type: Article

References (27)

1. Kennedy JC, Pettier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6:143-8.
2. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134:207-14.
3. Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin Exp Dermatol 1999; 24:143-8.
4. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146:552-67.
5. Henderson BW, Gollnick SO, Snyder JW et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 2004; 64:2120-6.
6. Wong TW, Tracy E, Oseroff AR, Baumann H. Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. Cancer Res 2003; 63:3812-18.
7. Takahashi H, Itoh Y, Miyauchi Y et al. Activation of two caspase cascades, caspase 8/3/6 and caspase 9/3/6, during photodynamic therapy using a novel photosensitizer, ATX-S10(Na), in normal human keratinocytes. Arch Dermatol Res 2003; 295:242-8.
8. Nakajima S, Sakata I, Takemura T et al. Tumor localizing and photosensitization of photo-chlorin ATX-S10. In: Photodynamic Therapy and Biomedical Lasers (Spinelli P, dal Fante M, Marchesini R, eds). Amsterdam: Elsevier, 1992: 531-4.
9. Tajiri H, Yokoyama K, Boku N et al. Fluorescent diagnosis of experimental gastric cancer using a tumor-localizing photosensitizer. Cancer Lett 1997; 111:215-20.
10. Nakajima S, Sakata I, Hirano T, Takemura T. Therapeutic effect of interstitial photodynamic therapy using ATX-S10(Na) and a diode laser on radio-resistant SCC II tumors of C3H/He mice. Anticancer Drugs 1998; 9:539-43.
11. Takahashi H, Itoh Y, Nakajima S et al. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin. Photodermatol Photoimmunol Photomed 2004; 20:257-65.
12. Clingen PH, Arlett CF, Cole J et al. Correlation of UVC and UVB cytotoxicity with the induction of specific photoproducts in T-lymphocytes and fibroblasts from normal human donors. Photochem Photobiol 1995; 61:163-70.
13. Brash DE, Rudolph JA, Simon J et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinomas. Proc Nutl Acad Sci USA 1991; 88:10124-8.
14. Ahmed NU, Ueda M, Nikaido O et al. High levels of 8-hydroxy-2′- deoxyguanosine appear in normal human epidermis after a single dose of ultraviolet radiation. Br J Dermatol 1999; 140:226-31.
15. Budiyanto A, Ahmed NU, Wu A et al. Protective effect of topically applied olive oil against photocarcinogenesis following UVB exposure of mice. Carcinogeneis 2000; 21:2085-90.
16. Cheng KC, Cahill DS, Kasai H et al. 8-hydroxyguanibe, an abundant form of oxidative DNA damage causes G to T and A to C substitution. J Biol Chem 1992; 267:166-72.
17. Nishigori C, Wang S, Miyakoshi J et al. Mutation in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation. Proc Natl Acad Sci USA 1994; 91:7189-93.
18. Toyokuni S, Tanaka M, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis. Lab Invest 1997; 76:365-74.
19. Mori T, Nakane M, Hattori T et al. Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4) photoproduct from the same mouse immunized with ultraviolet-irradiated DNA. Photochem Photobiol 1991; 54: 225-32.
20. Freeman SE, Hacham H, Gange RW et al. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 1989; 86:5605-9.
21. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol 1992; 14:275-92.
22. Eveno E, Bourre F, Quilliet X et al. Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res 1995; 55:4325-32.
23. Mitchell DL, Haipek CA, Clarkson JM. (6-4) Photoproducts are removed from the DNA of UV-irradiated mammalian cells more efficiently than cyclobutane pyrimidine dimers. Mutat Res 1985; 143:109-12.
24. Slender IM, Bech-Thomsen N, Poulsen T et al. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997; 66:493-6.
25. Sharfaei S, Viau G, Lui H et al. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol 2001; 144:1207-14.
26. Robinson DJ, Collins P, Stringer MR et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol (Stockt) 1999; 79:451-5.
27. Itoh Y, Ninomiya Y, Tajima S et al. Photodynamic therapy of acne vulgaris with topical d-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001 ; 144:575-9.